Limited is an Indian multinational pharmaceutical company based in Mumbai. It manufactures and markets over 350 formulations and 80 Active Pharmaceutical Ingredients (APIs) across global healthcare ***** & MilestonesThe stock trades around ₹1,641 to ₹1,646 on the National Stock ***** reached a fresh 52-week high of ₹1,658.00 during intraday trading on May 18, ***** stock shows a strong monthly return of over 9.12%, outperforming broader ***** research agencies recently upgraded the stock's market rating to a Buy.Q3 FY25-26 Financial SummaryRevenue: Stands at ₹2,392.50 crore, marking a 6.55% year-on-year ***** Profit: Reached ₹533.35 crore, up 15.17% ***** Profit: Reported at ₹363.67 crore, demonstrating an explosive 31.59% ***** Business OperationsThe firm is a global leader in Disease-Modifying Anti-Rheumatic Drugs for rheumatoid ***** maintains a dominant market share in pain management, anti-malarials, and ***** 79% of its API and intermediates turnover comes from international exports across 100+ ***** enterprise operates 15 API and 11 formulation manufacturing hubs globally.